Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Low Back Pain

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
PainLow Back Pain
Interventions
DRUG

BEMA Buprenorphine

buccal soluble film; applied to the buccal mucosa twice daily

Trial Locations (1)

Unknown

Marietta

All Listed Sponsors
lead

BioDelivery Sciences International

INDUSTRY

NCT01431742 - Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Low Back Pain | Biotech Hunter | Biotech Hunter